BUY BSE Ltd. — Osho Krishan, Angel One
byOsho Krishan, Angel OneHorizon: Swing (≤2wk)8 Sept 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·9 Sept · today
FTSE-BSE inclusion could open global index route for NSE shares
NewsHbl·8 Sept · yesterday
Deepa Jewellers IPO listing today: GMP at ₹25.5; Share price prediction ahead of NSE, BSE debut
NewsLivemint·8 Sept · yesterday
FTSE-BSE inclusion could open global index route for NSE shares
NewsHbl·7 Sept · yesterday
SEBI circular on CAS impact: Groww, Angel One, BSE shares jump up to 8% - What regulator said and investors should know
NewsLivemint·4 Sept · 4d ago
MCX, BSE shares in focus: Which exchange operator is Bernstein betting on
NewsCnbc-Tv18·9 Sept · today
Will BSE shares recover from CAS hit? HDFC Securities rates stock 'add', sees revival in derivatives volumes
NewsEt-Markets·8 Sept · today
BSE shares surge 10% in just 3 sessions. What’s driving the rally?
NewsEt-Markets·7 Sept · 2d ago
BSE, MCX remain buy-on-decline plays; Chola Securities prefers dividend stocks
NewsCnbc-Tv18·7 Sept · 2d ago
ESDS Software Solution IPO listing today: GMP at ₹247; Share price prediction ahead of NSE, BSE debut
NewsLivemint·4 Sept · 5d ago
BSE shares fall 4% to snap 3-day rally as Bernstein forecasts up to 17% downside
NewsEt-Markets·9 Sept · today
BSE shares slip 3% exchange flags lower volumes due to CAS
NewsEt-Markets·2 Sept · 6d ago
BSE shares slip 3% after exchange flags CAS-driven volume decline
NewsEt-Markets·2 Sept · 6d ago
Why BSE shares are falling today - CAS impact or some other trigger? Details here
NewsLivemint·2 Sept · 6d ago
Symbiotec Pharmalab IPO listing: Shares list at a 1% discount on BSE
NewsLivemint·1 Sept · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

